FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043196060> ?p ?o ?g. }

• W3043196060 abstract "Osteoarthritis is a chronic joint disease which has a serious impact on the health and quality of life of affected humans and animals. As an inhibitor of inducible nitric oxide synthase (iNOS), aminoguanidine (AG) displays anti-inflammatory effects. The purpose of the present study was to investigate the effect of AG on the expression of iNOS and cyclooxygenase-2 (COX-2), and the activity of the NF-κB signaling pathway in rat chondrocytes stimulated by interleukin-1β (IL-1β). The viability of chondrocytes treated with AG (0.3, 1 or 3 mM) alone was determined using a Cell Counting Kit-8 assay. Subsequently, the chondrocytes were treated with either 10 ng/ml IL-1β alone, or co-treated with increasing concentrations of AG (0.3, 1 or 3 mM) and 10 ng/ml IL-1β. The protein levels of COX-2, iNOS, phosphorylated (p)-p65, p65, p-NF-κβ inhibitor α (IκBα), IκBα, p-inhibitor of NF-κβ-β (IKKβ) and IKKβ were evaluated by western blotting. NF-κB translocation was determined by immunofluorescence analysis. Western blotting and reverse transcription-quantitative PCR were used to detect expression levels of relevant proteins/genes. The results suggested that the inhibitory effect of AG on the protein and gene expression levels of iNOS and COX-2 in IL-1β-treated chondrocytes was dose-dependent. In addition, AG decreased the level of phosphorylation of IKKβ, IκBα and NF-κB p65, the degradation of IKKβ, IκBα and p65, and the translocation of NF-κB in IL-1β-stimulated chondrocytes. The most significant inhibitory effect of AG was observed at a concentration of 1 mM. Therefore, the present study suggested that AG may serve as a potential agent to reduce the inflammatory response of chondrocytes stimulated by IL-1β." @default.
• W3043196060 created "2020-07-23" @default.
• W3043196060 creator A5009682806 @default.
• W3043196060 creator A5018758426 @default.
• W3043196060 creator A5039441880 @default.
• W3043196060 creator A5039600798 @default.
• W3043196060 creator A5044367029 @default.
• W3043196060 creator A5054529993 @default.
• W3043196060 creator A5060226649 @default.
• W3043196060 creator A5065995452 @default.
• W3043196060 creator A5083516131 @default.
• W3043196060 creator A5085985102 @default.
• W3043196060 date "2020-07-17" @default.
• W3043196060 modified "2023-10-16" @default.
• W3043196060 title "Aminoguanidine inhibits IL‑1β‑induced protein expression of iNOS and COX‑2 by blocking the NF‑κB signaling pathway in rat articular chondrocytes" @default.
• W3043196060 cites W1592352685 @default.
• W3043196060 cites W1710938496 @default.
• W3043196060 cites W1820446219 @default.
• W3043196060 cites W1948579785 @default.
• W3043196060 cites W1999243993 @default.
• W3043196060 cites W2004745975 @default.
• W3043196060 cites W2017578552 @default.
• W3043196060 cites W2018126325 @default.
• W3043196060 cites W2020279431 @default.
• W3043196060 cites W2026123588 @default.
• W3043196060 cites W2027831505 @default.
• W3043196060 cites W2049582838 @default.
• W3043196060 cites W2061410906 @default.
• W3043196060 cites W2066868344 @default.
• W3043196060 cites W2070276449 @default.
• W3043196060 cites W2070789464 @default.
• W3043196060 cites W2075099715 @default.
• W3043196060 cites W2078961281 @default.
• W3043196060 cites W2085788584 @default.
• W3043196060 cites W2085834708 @default.
• W3043196060 cites W2093989883 @default.
• W3043196060 cites W2097256289 @default.
• W3043196060 cites W2103465847 @default.
• W3043196060 cites W2107277218 @default.
• W3043196060 cites W2117552900 @default.
• W3043196060 cites W2128001125 @default.
• W3043196060 cites W2134414536 @default.
• W3043196060 cites W2136870660 @default.
• W3043196060 cites W2137235893 @default.
• W3043196060 cites W2141793532 @default.
• W3043196060 cites W2164993228 @default.
• W3043196060 cites W2171444572 @default.
• W3043196060 cites W2185268484 @default.
• W3043196060 cites W2208379232 @default.
• W3043196060 cites W2211984433 @default.
• W3043196060 cites W2237822184 @default.
• W3043196060 cites W2272819852 @default.
• W3043196060 cites W2301302578 @default.
• W3043196060 cites W2303694963 @default.
• W3043196060 cites W2331957061 @default.
• W3043196060 cites W2409283684 @default.
• W3043196060 cites W2417893992 @default.
• W3043196060 cites W2483225871 @default.
• W3043196060 cites W2522712150 @default.
• W3043196060 cites W2582214777 @default.
• W3043196060 cites W2593978377 @default.
• W3043196060 cites W2598455898 @default.
• W3043196060 cites W2601029872 @default.
• W3043196060 cites W2747571590 @default.
• W3043196060 cites W2763462056 @default.
• W3043196060 cites W2775660399 @default.
• W3043196060 cites W797433758 @default.
• W3043196060 cites W1964184380 @default.
• W3043196060 doi "https://doi.org/10.3892/etm.2020.9021" @default.
• W3043196060 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7401635" @default.
• W3043196060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32765755" @default.
• W3043196060 hasPublicationYear "2020" @default.
• W3043196060 type Work @default.
• W3043196060 sameAs 3043196060 @default.
• W3043196060 citedByCount "5" @default.
• W3043196060 countsByYear W30431960602021 @default.
• W3043196060 countsByYear W30431960602022 @default.
• W3043196060 countsByYear W30431960602023 @default.
• W3043196060 crossrefType "journal-article" @default.
• W3043196060 hasAuthorship W3043196060A5009682806 @default.
• W3043196060 hasAuthorship W3043196060A5018758426 @default.
• W3043196060 hasAuthorship W3043196060A5039441880 @default.
• W3043196060 hasAuthorship W3043196060A5039600798 @default.
• W3043196060 hasAuthorship W3043196060A5044367029 @default.
• W3043196060 hasAuthorship W3043196060A5054529993 @default.
• W3043196060 hasAuthorship W3043196060A5060226649 @default.
• W3043196060 hasAuthorship W3043196060A5065995452 @default.
• W3043196060 hasAuthorship W3043196060A5083516131 @default.
• W3043196060 hasAuthorship W3043196060A5085985102 @default.
• W3043196060 hasBestOaLocation W30431960601 @default.
• W3043196060 hasConcept C100175707 @default.
• W3043196060 hasConcept C104317684 @default.
• W3043196060 hasConcept C11960822 @default.
• W3043196060 hasConcept C153911025 @default.
• W3043196060 hasConcept C178790620 @default.
• W3043196060 hasConcept C184235292 @default.
• W3043196060 hasConcept C185592680 @default.
• W3043196060 hasConcept C190283241 @default.
• W3043196060 hasConcept C2777622882 @default.
• W3043196060 hasConcept C2777730290 @default.

• next